Trials / Sponsors / Aerpio Therapeutics
Aerpio Therapeutics
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solut Ocular Hypertension, Primary Open Angle Glaucoma | Phase 1 | 2019-05-02 |
| Completed | Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers IBD | Phase 1 | 2016-08-01 |
| Completed | Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778 Healthy | Phase 1 | 2016-07-01 |
| Completed | Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO Retinal Vein Occlusion | Phase 2 | 2015-01-01 |
| Completed | The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edem Diabetic Macular Edema (DME) | Phase 2 | 2014-01-01 |
| Completed | Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema Diabetic Macular Edema (DME) | Phase 1 / Phase 2 | 2012-09-01 |